Targeting of the innate immunity/inflammation as complementary anti-tumor therapies
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting of the innate immunity/inflammation as complementary anti-tumor therapies
Authors
Keywords
-
Journal
ANNALS OF MEDICINE
Volume 43, Issue 8, Pages 581-593
Publisher
Informa UK Limited
Online
2011-07-14
DOI
10.3109/07853890.2011.595732
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of Transforming Growth Factor-β Signaling in Mammary Fibroblasts Enhances CCL2 Secretion to Promote Mammary Tumor Progression through Macrophage-Dependent and -Independent Mechanisms
- (2015) Stacey L. Hembruff et al. NEOPLASIA
- Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model
- (2011) Iori Sakai et al. CANCER SCIENCE
- Toll-like receptor 9 agonists as cancer therapeutics
- (2011) Udo Holtick et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- JAK1 Activates STAT3 Activity in Non-Small-Cell Lung Cancer Cells and IL-6 Neutralizing Antibodies Can Suppress JAK1-STAT3 Signaling
- (2011) L. Song et al. MOLECULAR CANCER THERAPEUTICS
- Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
- (2011) D. Iliopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
- (2010) A Santoro et al. BRITISH JOURNAL OF CANCER
- A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma
- (2010) J M G Larkin et al. BRITISH JOURNAL OF CANCER
- Why not treat human cancer with interleukin-1 blockade?
- (2010) Charles A. Dinarello CANCER AND METASTASIS REVIEWS
- Targeted therapies of cancer: Angiogenesis inhibition seems not enough
- (2010) Ilse Roodink et al. CANCER LETTERS
- Mechanisms linking pathogens-associated inflammation and cancer
- (2010) Chiara Porta et al. CANCER LETTERS
- Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
- (2010) G. Germano et al. CANCER RESEARCH
- Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
- (2010) K. Movahedi et al. CANCER RESEARCH
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Cancer and Inflammation: Implications for Pharmacology and Therapeutics
- (2010) F Balkwill et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Molecular Pathways Linking Inflammation and Cancer
- (2010) A. Mantovani CURRENT MOLECULAR MEDICINE
- Interleukin-1β regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1α
- (2010) Antonella Naldini et al. EUROPEAN JOURNAL OF CANCER
- Interleukin-6 in bone metastasis and cancer progression
- (2010) Tasnim Ara et al. EUROPEAN JOURNAL OF CANCER
- Chemokines in cancer related inflammation
- (2010) Paola Allavena et al. EXPERIMENTAL CELL RESEARCH
- Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer
- (2010) Alexander Schultze et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Control of immune response by amino acid metabolism
- (2010) Ursula Grohmann et al. IMMUNOLOGICAL REVIEWS
- CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
- (2010) Saima Hassan et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of Focal Adhesion Kinase in Patients With Endometrial Cancer
- (2010) Boris Gabriel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells
- (2010) Yan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Critical Role of Airway Macrophages in Modulating Disease Severity during Influenza Virus Infection of Mice
- (2010) M. D. Tate et al. JOURNAL OF VIROLOGY
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
- (2010) Gareth J Morgan et al. LANCET
- A Review of Trabectedin (ET-743): A Unique Mechanism of Action
- (2010) Maurizio D'Incalci et al. MOLECULAR CANCER THERAPEUTICS
- Nanoscale architecture of integrin-based cell adhesions
- (2010) Pakorn Kanchanawong et al. NATURE
- The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
- (2009) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- C/EBP regulates transcription factors critical for proliferation and survival of multiple myeloma cells
- (2009) R. Pal et al. BLOOD
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β
- (2009) Taku Nagai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone
- (2009) Xin Li et al. CANCER RESEARCH
- Blockade of a Chemokine, CCL2, Reduces Chronic Colitis-Associated Carcinogenesis in Mice
- (2009) B. K. Popivanova et al. CANCER RESEARCH
- v 3/ v 5 Integrins-FAK-RhoB: A Novel Pathway for Hypoxia Regulation in Glioblastoma
- (2009) N. Skuli et al. CANCER RESEARCH
- Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance
- (2009) Yu-Ying Chen et al. CANCER SCIENCE
- PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)
- (2009) Laure Dossus et al. CARCINOGENESIS
- The chemokine system in cancer biology and therapy
- (2009) Alberto Mantovani et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours
- (2009) Vanesa Gregorc et al. EUROPEAN JOURNAL OF CANCER
- Targeting focal adhesion kinase signaling in tumor growth and metastasis
- (2009) Joerg Schwock et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model
- (2009) Stefan Rozel et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
- (2009) Kellie A. Charles et al. JOURNAL OF CLINICAL INVESTIGATION
- The Role of Macrophage-Derived IL-1 in Induction and Maintenance of Angiogenesis
- (2009) Y. Carmi et al. JOURNAL OF IMMUNOLOGY
- Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
- (2009) G. Solinas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study
- (2009) Luigi Laghi et al. LANCET ONCOLOGY
- Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
- (2009) John A. Lust et al. MAYO CLINIC PROCEEDINGS
- TNF-α and its inhibitors in cancer
- (2009) Inès Zidi et al. MEDICAL ONCOLOGY
- Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines
- (2009) Wu Huanwen et al. Molecular Cancer
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models
- (2009) F. Shojaei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth
- (2009) Stacy Porvasnik et al. PROSTATE
- Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
- (2008) Hal M. Hoffman et al. ARTHRITIS AND RHEUMATISM
- Interleukin-6 predicts recurrence and survival among head and neck cancer patients
- (2008) Sonia A. Duffy et al. CANCER
- Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver Tumorigenesis
- (2008) Toshiharu Sakurai et al. CANCER CELL
- Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model
- (2008) Asahi Ito et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers
- (2008) J A Burger et al. LEUKEMIA
- Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia
- (2008) Emmanuelle Tavernier-Tardy et al. LEUKEMIA RESEARCH
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
- (2008) Willscott E. Naugler et al. TRENDS IN MOLECULAR MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started